These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3111715)

  • 1. Migraine and the lupus anticoagulant. Case reports and review of the literature.
    Levine SR; Joseph R; D'Andrea G; Welch KM
    Cephalalgia; 1987 Jun; 7(2):93-9. PubMed ID: 3111715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupus anticoagulant. A report of 8 cases.
    Agarwal MB; Agarwal UM
    J Assoc Physicians India; 1991 Mar; 39(3):243-5. PubMed ID: 1908857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation of antiphospholipid antibodies to thrombotic phenomena and clinical activity of systemic lupus erythematosus].
    Font J; Cervera R; Casals FJ; Bové A; Guerrero A; López-Soto A; Ingelmo M; Urbano-Márquez A
    Med Clin (Barc); 1988 Mar; 90(12):490-3. PubMed ID: 3134583
    [No Abstract]   [Full Text] [Related]  

  • 4. Lupus anticoagulant, antiphospholipid antibodies and migraine.
    Hogan MJ; Brunet DG; Ford PM; Lillicrap D
    Can J Neurol Sci; 1988 Nov; 15(4):420-5. PubMed ID: 3145136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies.
    Levine SR; Welch KM
    Arch Neurol; 1987 Aug; 44(8):876-83. PubMed ID: 3115237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus anticoagulant, anticardiolipin antibody or antiphospholipid syndrome?
    Malaviya AN
    J Assoc Physicians India; 1991 Mar; 39(3):239-41. PubMed ID: 1908856
    [No Abstract]   [Full Text] [Related]  

  • 7. The association of lupus anticoagulant and anti-DNA binding in patients with systemic lupus erythematosus.
    Bennett RE; Calabrese LH; Lucas FV; Clough JD
    Cleve Clin Q; 1985; 52(2):115-8. PubMed ID: 3928199
    [No Abstract]   [Full Text] [Related]  

  • 8. [Screening method of lupus anticoagulants using coagulation technics: clinical application to patients with SLE and habitual abortion].
    Motoi S; Suehisa E; Nishimura K; Amino N; Miyai K; Mori M; Tanizawa O
    Rinsho Byori; 1988 Jan; 36(1):71-6. PubMed ID: 3130514
    [No Abstract]   [Full Text] [Related]  

  • 9. [The antiphospholipid antibody syndrome: its pathogenesis and clinico-morphological manifestations].
    Zerbino DD; Lukasevich LL; Bilynskaia OA
    Arkh Patol; 1990; 52(4):65-9. PubMed ID: 2117434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids.
    Markus HS; Hopkinson N
    J Neurol; 1992 Jan; 239(1):39-42. PubMed ID: 1541968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus circulating anticoagulant: report of a case.
    Haber-Cohen A; Burke JE
    J Oral Maxillofac Surg; 1988 Aug; 46(8):688-9. PubMed ID: 3135371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Presentation of 20 cases of lupus anticoagulant. Proposal for a methodology for its study].
    Mompel Sanjuán A; Abad Gosalbez A; García Pérez A; Marco Vera P
    Sangre (Barc); 1988 Aug; 33(4):306-9. PubMed ID: 3142061
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical value of determining the levels of lupus anticoagulant and anti-cardiolipin antibodies].
    Alekberova ZS; Nasonov EL; Prudnikova LZ; Aleksandrova LZ; Kurdiashova VF
    Ter Arkh; 1988; 60(7):84-7. PubMed ID: 3145584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity.
    Rustin MH; Bull HA; Machin SJ; Isenberg DA; Snaith ML; Dowd PM
    J Invest Dermatol; 1988 May; 90(5):744-8. PubMed ID: 3129519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
    Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Presence of lupus-type anticoagulant, in systemic lupus erythematosus and other clinical entities].
    Raleigh-Rosendo R; Diez-Ewald M; Vizcaíno G; Fereira H; Arteaga-Vizcaíno M; Arreaza M
    Invest Clin; 1990; 31(1):45-55. PubMed ID: 2128614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on evaluation of circulating anticoagulant in borderline cases].
    Ishii K; Himizu M; Ono F; Yamamoto M; Kawai Y; Watanabe K; Iri H
    Rinsho Byori; 1989 Dec; 37(12):1379-84. PubMed ID: 2515324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical manifestations associated with the presence of lupus anticoagulant].
    Miori L; Bellosta M; Miori E; Rabbiosi G
    G Ital Dermatol Venereol; 1989 Mar; 124(3):107-10. PubMed ID: 2509330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus anticoagulants in children.
    Singh AK; Rao KP; Kizer J; Lazarchick J
    Ann Clin Lab Sci; 1988; 18(5):384-7. PubMed ID: 3140708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The antiphospholipid antibody syndrome: a new clinical and therapeutic viewpoint in systemic lupus erythematosus].
    Bravo-Vargas G; Lavalle-Montalvo C
    Gac Med Mex; 1988; 124(1-2):39-42. PubMed ID: 3145236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.